Urinary mannose-binding lectin is a biomarker for predicting the progression of IgA nephropathy
Clinical and Experimental Immunology, 05/07/2012
Liu LI et al. – Urinary mannose–binding lectin (MBL) can be a reliable non–invasive biomarker for evaluating disease severity and predicting the prognosis of IgAN. This is the first report on this issue.